Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 1, 2000, Pages

  Roccella, E J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Eclampsia; Hypertension; Preeclampsia; Pregnancy; Treatment

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; METOPROLOL; NADOLOL; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN;

CLINICAL FEATURE; CONGENITAL MALFORMATION; CONVULSION; DELIVERY; DIAGNOSTIC APPROACH ROUTE; DIASTOLIC BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; DRUG INDICATION; ECLAMPSIA; EDEMA; FEMALE; FETUS MONITORING; FETUS WASTAGE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SOMNOLENCE; SYNDROME DELINEATION; TREATMENT INDICATION;

EID: 0033891361     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107928     Document Type: Article

References (201)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
2. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy
3. Obstetric-gynecologic terminology
4. Management of hypertension in pregnancy: Executive summary Australasian Society for the Study of Hypertension in Pregnancy
5. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy
6. The detection, investigation and management of hypertension in pregnancy, full consensus statement of recommendations from the Council of the Australasian Society for the Study of Hypertension in Pregnancy (ASSHP)
7. Indirect blood pressure measurement in pregnancy: Korotkoff phase 4 versus phase 5
8. Diastolic blood pressure in pregnancy: Phase IV or phase V Korotkoff sounds?
9. The measurement of diastolic blood pressure during pregnancy: Which Korotkoff phase should be used?
10. Diastolic blood pressure in pregnancy: Phase IV or phase V Korotkoff sounds?
11. Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V
12. Evaluation of a definition of pre-eclampsia
13. Should the definition of preeclampsia include a rise in diastolic blood pressure ≥15 mm Hg?
14. Validity of dipstick analysis as a method of screening for proteinuria in pregnancy
15. Urinary dipstick protein: A poor predictor of absent or severe proteinuria
16. Proteinuria and its assessment in normal and hypertensive pregnancy
17. Maternal uterine vascular lesions in the hypertensive complications of pregnancy
18. Trophoblast invasion and placentation in the human: Morphological aspects
19. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: A strategy for successful endovascular invasion?
20. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts
21. The placenta in pregnancy hypertension
22. A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q
23. A class I antigen, HLA-G, expressed in human trophoblasts
24. Nulliparous preeclampsia (PE) is associated with placental expression of a variant allele of the new histocompatibility gene: HLA-G
25. Review: Immunobiology of preeclampsia
26. Risk factors associated with preeclampsia in healthy nulliparous women
27. Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae?
28. Second trimester ambulatory blood pressure in nulliparous pregnancy: A useful screening test for pre-eclampsia?
29. Renal and cardiovascular alterations
30. Central hemodynamic observations in untreated preeclamptic patients
31. A study of angiotensin II pressor response throughout primigravid pregnancy
32. Circadian blood pressure variability in healthy and complicated pregnancies
33. The duration of hypertension in the puerperium of preeclamptic women: Relationship with renal impairment and week of delivery
34. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production
35. Thromboxane A2 synthesis in pregnancy-induced hypertension
36. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: A multicenter prospective study
37. Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy
38. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat
39. Prolonged blockage of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation
40. The role of nitric oxide (NO) in the pathogenesis of preeclampsia
41. Urinary levels of nitric oxide metabolites in normal pregnancy and preeclampsia
42. Preeclampsia: An endothelial cell disorder
43. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: Morphological and biochemical evidence
44. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin
45. Selective effects of preeclamptic sera on human endothelial cell procoagulant protein expression
46. Lipid peroxidation in pregnancy: New perspectives on preeclampsia
47. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Complications for oxidative stress
48. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy
49. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies
50. Pre-eclampsia - A state of sympathetic overactivity
51. Abnormal 1,25-dihydroxyvitamin D metabolism in preeclampsia
52. Lower serum ionized calcium and abnormal calciotropic hormone levels in pre-eclampsia
53. Glucose intolerance in women with preeclampsia
54. Importance of abnormal glucose tolerance (hypoglycemia and hyperglycemia) in the etiology of pre-eclampsia
55. Glucose intolerance as a predictor of hypertension in pregnancy
56. Endothelial dysfunction in preeclampsia
57. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes
58. Left ventricular mechanics in preeclampsia
59. Peripartum heart failure: Idiopathic cardiomyopathy or compounding cardiovascular events?
60. Renal physiology, disease in pregnancy in the kidney
61. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis
62. Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum
63. Pathology of the kidney, liver, and brain
64. Acute renal failure in pregnancy
65. Hypocalciuria in preeclampsia
66. Sodium excretion in normal and hypertensive pregnancy: A prospective study
67. The renin-angiotensin system in normal and hypertensive pregnancy and in ovarian function
68. Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: A meta-analysis
69. Atrial natriuretic factor in normal and hypertensive pregnancy
70. Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy
71. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia
72. Platelet and coagulation abnormalities
73. A prospective study investigating the mechanism of thrombocytopenia in pre-eclampsia
74. How often does maternal preeclampsia-eclampsia incite thrombocytopenia in the fetus?
75. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelet syndrome, and postpartum acute renal failure: Different clinical syndromes or just different names?
76. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy
77. Transcranial assessment of maternal cerebral blood flow velocity in patients with pre-eclampsia
78. Association of cerebral perfusion pressure with headache in women with pre-eclampsia
79. Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy
80. Cerebral imaging in eclampsia: Magnetic resonance imaging versus computed tomography
81. Electroencephalogram and computerised cerebral tomography findings in eclampsia
82. Multifocal cerebral hemorrhage in eclampsia and severe pre-eclampsia
83. Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia
84. Prediction and differential diagnosis
85. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension
86. Low-dose aspirin to prevent preeclampsia in women at high risk
87. Outcome of pregnancy in women with moderate or severe renal insufficiency
88. Chronic renal disease and pregnancy outcome
89. Pregnancy in women with impaired renal function
90. Comparison of pregnancy outcome between normotensive and hypertensive women with primary glomerulonephritis
91. Morphometric and neurodevelopmental outcome at age five years of the offspring of women who continued to exercise regularly throughout pregnancy
92. The one-year morphometric and neurodevelopmental outcome of the offspring of women who continued to exercise regularly throughout pregnancy
93. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy
94. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy
95. Maternal blood pressure and birthweight
96. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis
97. Treatment of hypertension in pregnant women
98. The prognosis of pregnancy in women with chronic hypertension
99. Diagnosis and management of chronic hypertension in pregnancy
100. Common complications of pregnancy: Hypertensive disorders in pregnancy
101. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension
102. Final report of study on hypertension during pregnancy: The effects of specific treatment on the growth and development of the children
103. Fortnightly review: Management of hypertension in pregnancy
104. Atenolol and fetal growth in pregnancies complicated by hypertension
105. Effect of atenolol on birth weight
106. Atenolol in essential hypertension during pregnancy
107. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study
108. Plasma volume determination in normal and preeclamptic pregnancies
109. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension
110. Effects of diuretics on plasma volume in pregnancies with long-term hypertension
111. Overview of randomised trials of diuretics in pregnancy
112. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy
113. Enalapril for pregnancy-induced hypertension: Acute renal failure in a neonate
114. Neonatal anuria with maternal angiotensin-converting enzyme inhibition
115. Neonatal renal failure: A complication of maternal antihypertensive therapy
116. Pregnancy outcome of intensive therapy in severe hypertension in first trimester
117. Pregnancy in renal disease
118. Primary glomerulonephritis and pregnancy
119. The kidney in pregnancy
120. Registry of pregnancy in dialysis patients
121. Pregnancy and dialysis
122. Pregnancy in chronic renal insufficiency and end-stage renal disease
123. Medical management of the pregnant transplant recipient
124. Circulatory congestion in obese hypertensive women: A subset of pulmonary edema in pregnancy
125. Pregnancy in women with renal disease and moderate renal insufficiency
126. Principles of drug transfer into breast milk and drug deposition in the nursing infant
127. Drugs in pregnancy and lactation
128. American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk
129. Management of hypertension during lactation
130. Suppressing lactation with oral diuretics
131. Drugs in milk
132. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy
133. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women
134. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women
135. ECPPA: Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women
136. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): A randomised trial for the prevention of pre-eclampsia and its complications
137. Low-dose aspirin therapy to prevent pre-eclampsia
138. A randomised trial of low dose aspirin for primiparae in pregnancy
139. Prevention of preeclampsia: A big disappointment
140. US Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes
141. Trial of calcium to prevent preeclampsia
142. Prevention of pre-eclampsia by linoleic acid and calcium supplementation: A randomized controlled trial
143. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: An Australian randomized trial
144. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population
145. Dietary calcium supplementation and prevention of pregnancy hypertension
146. Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers
147. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients
148. Calcium supplementation to prevent hypertensive disorders of pregnancy
149. Magnesium supplementation in pregnancy: A double-blind study
150. Magnesium supplementation during pregnancy: A double-double-blind randomized controlled clinical trial
151. The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension
152. A-randomised double blind placebo controlled trial of fish oil in high risk pregnancy
153. Eftects of fish oil supplementation in late pregnancy on blood pressure: A randomised controlled trial
154. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomised trial
155. Is oxidative stress the link in the two-stage model of pre-eclampsia?
156. Hypertension
157. An economic evaluation of daycare in the management of hypertension in pregnancy
158. Community-based home-care program for the management of pre-eclampsia: An alternative
159. Monitored outpatient management of mild gestational hypertension remote from term
160. Monitored outpatient management of mild gestational hypertension remote from term in teenage pregnancies
161. Does advanced maternal age affect pregnancy outcome in women with mild hypertension remote from term?
162. Out-patient management of toxaemia
163. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension?
164. Randomised controlled trial of day care for hypertension in pregnancy
165. A protocol for managing severe preeclampsia in the second trimester
166. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial
167. Aggressive or expectant management for patients with severe pre-eclampsia between 28-34 weeks' gestation: A randomized controlled trial
168. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: A randomized placebo-controlled study
169. Conservative management of severe preeclampsia remote from term
170. Spinal versus epidural anesthesia for cesarean section in severely preeclamptic patients: A retrospective survey
171. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia
172. Anesthesia-related deaths during obstetric delivery in the United States, 1979-1990
173. Which anticonvulsant for women with eclampsia?
174. Magnesium sulfate therapy in preeclampsia and eclampsia
175. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: An overview of the evidence from randomised trials
176. A randomised controlled trial of intravenous magnesium sulfate versus placebo in the management of women with severe pre-eclampsia
177. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia
178. Temporising management of severe pre-eclampsia with and without the HELLP syndrome
179. Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia
180. Antihypertensive treatment
181. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy
182. Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia
183. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies
184. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and psuedoemergencies?
185. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks
186. The combination of magnesium sulfate and nifedipine: A cause of neuromuscular blockade
187. Withdrawal of nifedipine capsules: Jeopardising the treatment of acute severe hypertension in pregnancy?
188. Withdrawal of nifedipine capsules: Jeopardising the treatment of acute severe hypertension
189. Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis
190. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis
191. Hypertensive disorders of pregnancy
192. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Subsequent pregnancy outcome and long-term prognosis
193. Change in paternity: A risk factor for preeclampsia in multiparas
194. Underlying disorders associated with severe early-onset preeclampsia
195. Increased frequency of genetic thrombophilia in women with complications of pregnancy
196. Thrombophilias and adverse outcomes of pregnancy - What should a clinician do?
197. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia
198. Eclampsia VII. Pregnancy outcome after eclampsia and long-term prognosis